Clinical studies recruiting near Katowice

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Centrum Medyczne Pratia - Katowice · AbbVie · NCT06602479 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Pratia Onkologia Katowice ( Site 1009) · Merck Sharp & Dohme LLC · NCT06136559 Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Followin
Phase 3 · Upper-Silesian Heart Center · Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi · NCT07195149 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Gyncentrum Sp. z o.o. · Takeda · NCT07108283 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0124 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Randomization of Single vs Multiple Arterial Grafts
NA · Medical University of Silesia (Katowice) · Weill Medical College of Cornell University · NCT03217006 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Emc Silesia Spolka z ograniczona odpowiedzialnoscia · Amgen · NCT07037433 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero · Eli Lilly and Company · NCT07483099 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero · Eli Lilly and Company · NCT07415044 Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI
NA · Medical University of Silesia in Katowice · Medical University of Silesia · NCT05966675 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Pratia Onkologia Katowice · argenx · NCT06544499 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Silmedic Sp. z o.o., Merz Investigational Site #0480115 · Merz Therapeutics GmbH · NCT07018700 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Górnoslaskie Centrum Zdrowia Dziecka im. sw. Jana Pawla II S · Bayer · NCT07192952 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963 Visugromab in Cachexia International Trial
Phase 2/Phase 3 · Pratia Onkologia Katowice · CatalYm GmbH · NCT07112196 A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero · Pfizer · NCT07470879 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero · Eli Lilly and Company · NCT06937086 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · NZOZ Silesian Urology Hospital · UroGen Pharma Ltd. · NCT06774131 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Pratia Onkologia Katowice · Loxo Oncology, Inc. · NCT05254743 Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Phase 1/Phase 2 · Pratia Onkologia Katowice · Heidelberg Pharma AG · NCT04879043 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0185 · Celgene · NCT05519085 A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no O
Phase 3 · SPSK nr 7 SUM w Katowicach Gornoslaskie Centrum Medyczne im · Actelion · NCT05179876 Implementation of a Pediatric ERAS-based Protocol in Intestinal Resection With Primary Anastomosis
NA · Michał Pasierbek · NCT07504549 A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Phase 3 · Centrum Medyczne Angelius Provita · Pfizer · NCT07029828 A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · NZOZ Medem · Gesynta Pharma AB · NCT07260669 A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT07503873 Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Phase 2 · Neurologia Śląska Centrum Medyczne · NMD Pharma A/S · NCT06414954 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Silmedic Sp. z o.o. · Exciva GmbH · NCT07284472 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Centrum Medyczne Pratia Katowice · Eli Lilly and Company · NCT06338995 Trifecta-Kidney cfDNA-MMDx Study
Phase N/A · Medical University of Silesia · University of Alberta · NCT04239703

Look up another city

Look up another condition